Lagap SA is a Swiss pharmaceutical Company, founded in 1959. Lagap manufactures and markets branded generic medicines. Lagap  is committed to satisfy the priority health care needs of the population by providing a wide range of pharmaceutical specialties with different dosage form: Tablets, Capsules, solution, granules and powder. Our portfolio was selected with due regard to public health relevance, evidence on efficacy and safety at the best affordable prices for everyone.  Lagap succeeded to maintain a sustainable presence in the international pharmaceutical market by delivering high quality products for more than 50 years. Our key goal strategy is leveraging our current product portfolio in existing markets and striving to develop new products and expand to new emergent markets.  

Sales Markets

Middle East Region (e.g. UAE); Africa; East Asia (e.g. China, Japan, Korea); South Asia (e.g. India, Pakistan, Sri Lanka); South East Asia (e.g. Thailand, Philippines, Singapore)

Meet us at

CPhI Worldwide 2021

Fiera Milano, Milan, Italy

9-11 November 2021

Book a meeting
View Our Exhibitor Profile

Contact information




View All Contact Info